Back
Cidara Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
81
CDTX
Cidara Therapeutics
Last Price:
$48.32
Seasonality Move:
0.55%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cidara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.69 | Sell |
| 20-day SMA: | 35.9 | Buy |
| 50-day SMA: | 27.68 | Buy |
| 200-day SMA: | 20.84 | Buy |
| 8-day EMA: | 46.33 | Buy |
| 20-day EMA: | 39.02 | Buy |
| 50-day EMA: | 30.96 | Buy |
| 200-day EMA: | 22.55 | Buy |
Cidara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.03 | Buy |
| Relative Strength Index (14 RSI): | 76.46 | Buy |
| Chaikin Money Flow: | 652572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Cidara Therapeutics Technical Analysis
| Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 48.30 while CDTX 8-day simple moving average is 48.69, which is a Sell signal.
-
The stock price of CDTX is 48.30 while Cidara Therapeutics 20-day SMA is 35.90, which makes it a Buy.
-
Cidara Therapeutics 50-day simple moving average is 27.68 while CDTX share price is 48.30, making it a Buy technically.
-
CDTX stock price is 48.30 and Cidara Therapeutics 200-day simple moving average is 20.84, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
81
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a BuyThe current Cidara Therapeutics [CDTX] share price is $48.30. The Score for CDTX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
1B
Price in USD:
48.30
Share Volume:
765.3K
Cidara Therapeutics 52-Week Range
52-Week High:
56.83
52-Week Low:
10.14
Buy
81
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?The Cidara Therapeutics stock price is 48.30 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 48.30 while CDTX 8-day exponential moving average is 46.33, which is a Buy signal.
-
The stock price of CDTX is 48.30 while Cidara Therapeutics 20-day EMA is 39.02, which makes it a Buy.
-
Cidara Therapeutics 50-day exponential moving average is 30.96 while CDTX share price is 48.30, making it a Buy technically.
-
CDTX stock price is 48.30 and Cidara Therapeutics 200-day simple moving average is 22.55, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $3.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.70 per share, and a decrease next year of $0.58 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 7.03, suggesting Cidara Therapeutics is a Buy
-
Cidara Therapeutics Relative Strength Index (RSI) is 76.46, which suggest Cidara Therapeutics is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics is ( - ), which suggest Cidara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics is ( - ), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.